Mark W. Sawicki - 11 Aug 2021 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Role: Chief Scientific Officer
Signature: /s/ Mark Sawicki
Issuer symbol: CYRX
Transactions as of: 11 Aug 2021
Net transactions value: -$3,935,607
Form type: 4
Filing time: 13 Aug 2021, 16:46:11 UTC
Next filing: 11 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYRX	Common Stock	Options Exercise	$605,475	+77,625	+215%	$7.80	113,698	11 Aug 2021	Direct
transaction	CYRX	Common Stock	Options Exercise	$143,391	+16,577	+15%	$8.65	130,275	11 Aug 2021	Direct
transaction	CYRX	Common Stock	Sale	$4,346,119	-74,453	-57%	$58.37	55,822	11 Aug 2021	Direct	F3
transaction	CYRX	Common Stock	Sale	$187,512	-3,172	-5.7%	$59.11	52,650	11 Aug 2021	Direct	F4
transaction	CYRX	Common Stock	Sale	$150,841	-2,521	-4.8%	$59.83	50,129	11 Aug 2021	Direct	F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYRX	Option to purchase common stock	Options Exercise	$0	-77,625	-100%	$0.000000^*	0	11 Aug 2021	Common Stock	77,625	$7.80	Direct	F1
transaction	CYRX	Option to purchase common stock	Options Exercise	$0	-16,577	-24%	$0.000000	51,423	11 Aug 2021	Common Stock	16,577	$8.65	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/48 of the 77,625 options originally granted vested on the 7th of each month for forty-eight months beginning June 7, 2015.
F2	1/48 of the 68,000 options originally granted vested on the 28th of each month for forty-eight months beginning April 28, 2018.
F3	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.85 to $58.84, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F4	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.85 to $59.51, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F5	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.81 to $59.90, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.